AMERICAN SHARED HOSPITAL SERVICES

AMS exhibits a capital structure with a debt-to-equity ratio of 0.72, indicating a moderate reliance on debt financing. The company's liquidity position is characterized by a current ratio of 0.77, suggesting that current liabilities exceed current assets, which is a red flag for short-term solvency. The company's cash and equivalents amount to $4,973,000, while its short-term debt stands at $16,843,000, resulting in a negative net cash position after subtracting total debt. Profitability metrics for AMS are concerning, with a return on equity of -2.6% and a return on assets of -1.12%, both significantly below industry norms. The company reported a net loss of $612,000 for the quarter, and its operating income was negative at $924,000, indicating operational inefficiencies. The gross profit margin of 18.2% is also below the industry median, suggesting cost management issues. AMS's revenue is primarily concentrated in the United States, with no significant international exposure disclosed in the available data. The company's business model is centered around direct patient services and cancer treatment offerings, which are its primary revenue drivers. However, the lack of geographic diversification increases its vulnerability to regional economic and regulatory changes. The company's growth trajectory is uncertain, with a negative operating income and a net loss in the most recent quarter. Capital expenditures for the quarter were $41,000, which is relatively low compared to industry peers, indicating a conservative approach to expansion. The company's liquidity risk is high, as it faces the possibility of not having sufficient cash to repay its $22,000,000 credit agreement with Fifth Third Bank at maturity. This risk is compounded by the absence of long-term debt, which limits its ability to refinance short-term obligations. Recent filings highlight several risk factors, including the company's reassessment of its ability to continue as a going concern due to events of default under its credit agreement. Management has also noted the potential for dilution through future offerings, which could impact shareholder value. The company's forward-looking statements include risks related to capital expenditures, earnings, liquidity, and compliance with debt covenants. These statements underscore the company's exposure to various operational and financial uncertainties.